Tag: AI chatbot

Browse our exclusive articles!

Microsoft-backed OpenAI Acknowledges User Complaints of GPT-4 Getting Lazier

Microsoft-backed OpenAI acknowledges user complaints of GPT-4 getting lazier. OpenAI confirms the issue and assures users that they are actively working on a fix to improve the AI chatbot's performance. Stay tuned for updates.

Google Infuses Bard AI Chatbot with New AI Model Gemini, Promising Superior Reasoning, Australia

Google's AI chatbot, Bard, is being enhanced with a new AI model called Gemini, promising superior reasoning abilities. This comes in response to a growing number of takedown requests related to harmful or incorrect information from AI technology like Bard, highlighting the need for targeted solutions like machine unlearning. While some experts prioritize teaching algorithms to forget specific data, others focus on faster learning and more efficient fact retrieval. The industry continues to debate the significance of machine unlearning in addressing the challenges of misinformation and harmful content.

OpenAI CEO Disapproves of ChatGPT’s Name, Considers Alternatives

OpenAI CEO dislikes ChatGPT's name, considers alternatives. Despite popularity, name remains a challenge. Altman's dissatisfaction underscores the complexities of naming successful AI chatbots.

AI Chatbot ChatGPT Easily Fooled Into Accepting Wrong Answers, Study Finds

Study finds that AI chatbot ChatGPT can easily be convinced of wrong answers, exposing a weakness in large language models' reasoning.

Google Unveils Gemini: Advanced AI Chatbot to Rival OpenAI’s ChatGPT, UK

Google unveils Gemini, an advanced AI chatbot to rival OpenAI's ChatGPT. With enhanced capabilities and offline functionality, Gemini aims to revolutionize the chatbot experience.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img